Mural Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mural Oncology and other ETFs, options, and stocks.About MURA
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2.
CEOCaroline J. Loew
CEOCaroline J. Loew
Employees116
Employees116
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees116
Employees116
MURA Key Statistics
Market cap36.34M
Market cap36.34M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume65.68K
Average volume65.68K
High today$2.10
High today$2.10
Low today$2.08
Low today$2.08
Open price$2.09
Open price$2.09
Volume73.06K
Volume73.06K
52 Week high$4.74
52 Week high$4.74
52 Week low$0.95
52 Week low$0.95
Stock Snapshot
The current Mural Oncology(MURA) stock price is $2.08, with a market capitalization of 36.34M. The stock trades at a price-to-earnings (P/E) ratio of -0.30.
As of 2025-11-22, Mural Oncology(MURA) stock has fluctuated between $2.08 and $2.10. The current price stands at $2.08, placing the stock +0.0% above today's low and -0.7% off the high.
The Mural Oncology(MURA)'s current trading volume is 73.06K, compared to an average daily volume of 65.68K.
In the last year, Mural Oncology(MURA) shares hit a 52-week high of $4.74 and a 52-week low of $0.95.
In the last year, Mural Oncology(MURA) shares hit a 52-week high of $4.74 and a 52-week low of $0.95.
People also own
Based on the portfolios of people who own MURA. This list is generated using Robinhood data, and it’s not a recommendation.